Abingdon Health Limited (ABDX) ORD GBP0.00025
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
7.00p
6.95p
11.25p
£13.27 million
7.00p
6.51p
5.60p
n/a
0.00p (0.00%) Previous:
0.00p
32,243
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/06/2024 | 30/06/2023 |
|---|---|---|
| Revenue (£m) | 6.13 | 4.04 |
| Profit before tax (£m) | (1.40) | (3.57) |
| Adjusted EPS (p): | (0.37) | (0.94) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Abingdon Health secures €2m contract with European biotech firm
12 June 2025 07:59
-
Abingdon Health president appointed to board of investee FOFH
4 June 2025 14:13
-
Abingdon Health inks deal to develop avian flu test
2 June 2025 07:56
-
€2m contract win for companion diagnostic test
12 June 2025 07:00
-
Update re. strategic partnership with FOFH
4 June 2025 07:00
-
Avian flu (H5N1) lateral flow test
2 June 2025 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.